Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank20
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-170.60M
↓ 104% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-83.47M
Historical baseline
PeriodValueYoY Change
TTM$-170.60M+11.3%
2024$-192.40M-127.3%
2023$-84.66M-168.9%
2022$-31.48M-68.1%
2021$-18.73M-536.3%
2020$-2.94M-